Increasing the Sensitivity of Cytogenetic Analysis of Hematologic Malignancies Through Cell Enrichment

In hematologic cancers, including B cell lymphomas and multiple myeloma, malignant and non-malignant cells are mixed in the bone marrow or peripheral blood at variable frequencies. Enrichment of lymphoid cells prior to further analysis using Fluorescence In Situ Hybridization (FISH) can enhance the sensitivity of this technique by increasing the presence of malignant cells. This improves the resolution of FISH in detecting chromosomal abnormalities in patient samples, particularly in cases where disease burden is low. This webinar is sponsored by STEMCELL Technologies and Molecular at Abbott.
Publish Date: February 27, 2021 Views: 0

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.